Notable Labs Ltd (NAS:NTBL)

$ 0.8 -0.01 (-1.23%) Market Cap: 7.21 Mil Enterprise Value: 967,000.00 PE Ratio: 0 PB Ratio: 0.48 GF Score: 18/100

Vascular Biogenics Ltd and Notable Labs Inc M&A Call Transcript
Feb 23, 2023
Q1 2022 Vascular Biogenics Ltd Earnings Call Transcript
May 17, 2022

Earnings
Vascular Biogenics Ltd KOL Event on Ovarian Cancer Transcript
Apr 11, 2022
Vascular Biogenics Ltd at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) - Fireside Chat Transcript
Feb 10, 2022
Q3 2021 Vascular Biogenics Ltd Earnings Call Transcript
Nov 15, 2021

Earnings
Q2 2021 Vascular Biogenics Ltd Earnings Call Transcript
Aug 16, 2021

Earnings
Q1 2021 Vascular Biogenics Ltd Earnings Call Transcript
May 11, 2021

Earnings
Vascular Biogenics Ltd Virtual R&D Day & Corporate Update Transcript
Apr 06, 2021
Q4 2020 Vascular Biogenics Ltd Earnings Call Transcript
Mar 25, 2021

Earnings
Q3 2020 Vascular Biogenics Ltd Earnings Call Transcript
Nov 16, 2020

Earnings
Q2 2020 Vascular Biogenics Ltd Earnings Call Transcript
Aug 13, 2020

Earnings
Q4 2019 Vascular Biogenics Ltd Earnings Call Transcript
Mar 19, 2020

Earnings
Q1 2019 Vascular Biogenics Ltd Earnings Call Transcript
May 15, 2019

Earnings
Q4 2018 Vascular Biogenics Ltd Earnings Call Transcript
Mar 28, 2019

Earnings

Q3 2020 Vascular Biogenics Ltd Earnings Call Transcript

Nov 16, 2020 / 01:30PM GMT

Transcript

Operator

Greetings. Welcome to VBL Therapeutics Third Quarter 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded. I would now like to turn over conference to your host, Michael Wood with LifeSci Advisors. Thank you. You may begin.

Michael Wood

LifeSci Advisors, LLC - MD of Communications

Thank you, operator. Good morning, and thank you all for participating in today's third quarter 2020 results and corporate update for VBL Therapeutics. Leading the call this morning will be Professor Dror Harats, CEO of VBL; and Amos Ron, the company's CFO. A press release with the company's financial results became available earlier this morning and can be found on the Investors page of the company's website at vblrx.com.

Before we begin, I'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that these forward-looking statements are the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.